DexCom(us:DXCM)

67.32

-1.42%

Updated on 2025-04-02

Open:67.85
Close:67.32
High:68.40
Low:66.30
Prev Close:68.29
Volume:3.22M
Turnover:216.04M
Turnover Ratio:0.82%
Shares:392.11M
MarketCap:26.40B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30395411920.13%31213
2024-03-31106436021225890.94%148386409
2023-12-31104537311319296.81%179318457
2023-09-30101236259790893.84%109336462
2023-06-3097736253905593.90%120354368
2023-03-3194636280766893.59%85325421
2022-12-3192536895777295.52%167321349
2022-09-3084136347266094.11%71285377
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Vanguard Group Inc4651318411.61%19094394.28%
2024-06-30Blackrock Inc.345193658.61%5967131.76%
2024-06-30State Street Corp163086824.07%938640.58%
2024-06-30Baillie Gifford & Co153259313.82%-362465-2.31%
2024-06-30Capital Research Global Investors119455272.98%-1490365-11.09%
2024-06-30Sands Capital Management, Llc106065032.65%-290261-2.66%
2024-06-30Fmr Llc97921712.44%4452234.76%
2024-06-30Geode Capital Management, Llc97234682.43%5452735.94%
2024-06-30Capital World Investors83100072.07%2378772.95%
2024-06-30Jpmorgan Chase & Co66819621.67%98536617.30%

About

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Address:6340 Sequence Drive

Market Movers